Data layers Raw facts Calculated Model prediction AI interpretation

Allotment Overview Calculated

Total Subscription Fees vs Public Offering Raise Amount

Subscription Tier Analysis Model prediction

Expected Lots Allotted by Subscription Tier

Pool A applications 200-100,000股, Pool B applications 300,000-2,098,800股. Expected lots allotted = "Approximate percentage of total shares applied for" as stated in the allotment announcement × shares applied ÷ lot size, taken directly from the announcement.

Capital Efficiency by Subscription Tier

Capital efficiency = Expected shares allotted ÷ shares applied × 100, i.e. the original "Approximate percentage of total shares applied for" value from the allotment announcement. The fewer shares applied for, the higher the capital efficiency.

Applicant Distribution by Subscription Tier

The vertical axis uses a logarithmic scale to better observe distribution differences across tiers of varying magnitudes. All four charts share the same x-axis; hover tooltips are synchronized.

Subscription Fee ÷ Allotted Market Value by Tier

Allotted market value = valid applicants × shares applied × (percentage applied for ÷ 100) × offer price; total handling fees = valid applicants × HKD 100; ratio = total fees ÷ allotted market value × 100%. Lower tiers have disproportionately high ratios due to very small allotments; ratios stabilize at higher tiers.

Allotment Results Subscription Tier List

Loading...

International Offering Raw facts

24.58
International oversubscription
137
Placee count
14
Cornerstone investors
123
Anchor investors

Cornerstone investors

Name Shares allotted % of global offering % of post-IPO shares Lock-up
BPV及华泰资本投资(就华泰背对背TRS及华泰客户TRS而言) 4,626,000 11.02% 1.68% 6 months
腾讯控股(3) 3,771,800 8.99% 1.37% 6 months
黄河 3,020,000 7.19% 1.09% 6 months
Prosper High 751,800 1.79% 0.27% 6 months
LAV实体(3) 1,887,600 4.50% 0.68% 6 months
LAV Star 943,800 2.25% 0.34% 6 months
LAV Star Opportunities 943,800 2.25% 0.34% 6 months
睿远 1,887,200 4.50% 0.68% 6 months
GSC Fund 1 547,400 1.30% 0.20% 6 months
Vision Fund 1 962,600 2.29% 0.35% 6 months
Horizon Fund 1 188,600 0.45% 0.07% 6 months
Horizon Next Fund 188,600 0.45% 0.07% 6 months
First Quarter Moon OFC —Phecda Fund 943,800 2.25% 0.34% 6 months
WWHCP(3) 377,400 0.90% 0.14% 6 months

International concentration

Rank % of international placing % of global offering
前1名 — —
AI AI Analysis AI interpretation deepseek-v4-pro · AI-generated
!
The following content is generated by an AI model based on historical IPO data. It does NOT constitute investment advice, solicitation, or recommendation. Past subscription patterns and post-listing performance do not guarantee future results. Data may contain inaccuracies — always verify against official HKEX filings and prospectuses before making any investment decision.

Market Sentiment

英派药业认购热度极高,超额认购2282.4倍,显示市场对生物医药板块的强烈追捧。中签率仅8.46%,远低于港股IPO平均水平,一手中签难度极大。最终发售价定于20.1港元,结合超额倍数,反映出定价相对保守,为二级市场留有一定想象空间。(以上为AI基于历史数据生成的评论。过往模式不保证未来结果。不构成投资建议。)

Tier Analysis

甲尾每手期望中签0.49手,乙头期望中签0.63手,乙头资金效率明显优于甲尾,未出现甲尾倒挂的异常。但考虑乙组500万港元的高门槛,小额申购者的绝对获配量仍有限。档位分布整体符合顶格回拨后的正态稀释规律,无明显结构性扭曲。(以上为AI基于历史数据生成的评论。过往模式不保证未来结果。不构成投资建议。券商手续费结构各异,实际成本可能不同。)

Demographics

内地申购者占比56.1%,处于近年生物科技板块的中高水平,反映内地资金对未盈利生物医药标的的跨境参与热情。男性占比59.8%,略高于女性,符合生物医药领域投资者性别分布常态。香港本地参与度41.8%,显示本地投资者亦保持较高兴趣。(以上为AI基于历史数据生成的评论。过往模式不保证未来结果。不构成投资建议。)

About this page

This page shows allotment analysis for Impact Therap-B (07630): one-lot hit rate, Pool A/B allotment distribution, oversubscription multiple, and grey-market and first-day performance. Data is parsed from the HKEX allotment results announcement. How allotment rates and clawback work is explained in How Hong Kong IPO Allotment Rates Work.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect